ロード中...
Inclusion of KI67 significantly improves performance of the PREDICT prognostication and prediction model for early breast cancer
BACKGROUND: PREDICT (http://www.predict.nhs.uk) is a prognostication and treatment benefit tool for early breast cancer (EBC). The aim of this study was to incorporate the prognostic effect of KI67 status in a new version (v3), and compare performance with the Predict model that includes HER2 status...
保存先:
| 出版年: | BMC Cancer |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4265394/ https://ncbi.nlm.nih.gov/pubmed/25472026 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-908 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|